For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview of Global Molecular Diagnostics market:
According to our latest research, the global Molecular Diagnostics market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Molecular diagnosis refers to applying molecular biology methods to detect changes in the structure or expression level of genetic material in patients to make a diagnosis. Molecular diagnosis mainly detects genes encoding various structural proteins, enzymes, antigen antibodies, and active immune molecules related to diseases. In this report, the molecular diagnostics market mainly includes manufacturers of molecular diagnostic reagents and instruments.
Multi-field applications of Molecular Diagnostics
At present, Molecular Diagnostics is widely used in Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Diseases, and other fields. For example, in the field of tumors, the occurrence of tumors is the result of the interaction of genes and the environment. The individualization and precision medicine of malignant tumors is of great significance. It plays a role in predicting prognosis and screening treatment options. In addition, in the field of genetic diseases, genetic diseases are diseases caused by changes in genetic material or control of pathogenic genes and are generally divided into chromosomal syndromes, single-gene genetic diseases, and polygenic genetic diseases. In recent years, Molecular Diagnostics technology has played an important role in the fields of genetic disease diagnosis and newborn screening. At present, with the continuous development of Molecular Diagnostics technology, clinical applications are becoming more and more extensive, and the market demand for reagents and instrument products required in the diagnostic process is increasing. The multi-field application of Molecular Diagnostics is one of the important factors driving the development of the industry.
Limitations of Molecular Diagnostics
At present, the clinical application and development of Molecular Diagnostics still face certain limitations. For example, due to the generally high sensitivity of its technologies, especially PCR and NGS technologies, there are many factors affecting the results, and the biggest problem is technical false positives and false negatives. For example, the isothermal amplification technique is a nucleic acid Molecular Diagnostics technique. In the process of establishing methods or detecting actual samples, the probability of false positive results caused by isothermal amplification technology is relatively high, which narrows its practical application range and fails to truly show its detection advantages. At present, to make the detection technology have high sensitivity and ensure the high specificity and repeatability of the test results, quality control is very important. The key lies in the establishment of standardized experimental operating procedures, standardized Molecular Diagnostics laboratories, and standardized diagnostic indicators. The limitations of Molecular Diagnostics are one of the challenges facing the development of the industry.
Company Overview:
Molbio Diagnostics specializes in the field of molecular diagnostics. Molbio Diagnostics, brings to the healthcare professionals worldwide the "TruelabTM Real Time quantitative micro-PCR system", that makes Real Time PCR testing simple and possible in all laboratories, in the field and in near-patient settings. The smart design of the hardware and the room temperature stable reagent microchip make the assay robust and affordable.
Mylab Discovery Solutions, a Dynamic Biotechnology company, develops and commercializes diagnostic kits that enable laboratories to obtain reliable, timely and actionable answers. The company offers a broad range of solutions for different markets, including clinical diagnostics, drug discovery, biomedical research, agrigenomics, and animal and food safety.
Molbio Diagnostics is one of the major players operating in the Molecular Diagnostics market, holding a share of 18.51% in 2023.
Segmentation Overview:
Instruments
Molecular diagnostic instruments mainly include nucleic acid extractors, PCR amplification instruments, nucleic acid molecular hybridization instruments, gene chip instruments, and gene sequencers.
Reagents
Molecular biology reagents are widely used to detect genetic material in cells and tissues. It mainly includes nucleic acid extraction reagents, nucleic acid detection reagents, etc.
Among different product types, Reagents segment is anticipated to contribute the largest market share in 2028.
Application Overview:
According to different fields of clinical application of Molecular Diagnostics, it is divided into Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Diseases. For example, in Oncology, Molecular Diagnostics is used for the prediction and diagnosis of tumor occurrence and can evaluate the effect of tumor treatment. In the field of Infectious Diseases, Molecular Diagnostics uses molecular biology principles and technical means to detect, analyze and diagnose disease-related molecules, which can help doctors diagnose patients' diseases more quickly and accurately. In the field of Neurological Diseases, products provide a powerful method for the detection and diagnosis of various neurological diseases. In the field of Genetic Testing, products play an important role in the fields of genetic disease diagnosis and newborn screening.
By application, the Infectious Diseases segment occupied the biggest share from 2018 to 2022.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Molecular Diagnostics market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global Molecular Diagnostics Market Report:
Market Size Estimates: Molecular Diagnostics market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: Molecular Diagnostics market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Molecular Diagnostics market
Segment Market Analysis: Molecular Diagnostics market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: Molecular Diagnostics market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the Molecular Diagnostics Market: Revenue and sales volume of major countries in each region
Molecular Diagnostics Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the Molecular Diagnostics market in major regions.
Molecular Diagnostics Industry Value Chain: Molecular Diagnostics market raw materials & suppliers, manufacturing process, distributors, downstream customers
Molecular Diagnostics Industry News, Policies & Regulations
Key players in the global Molecular Diagnostics market are covered in Chapter 12:
Molbio Diagnostics
bioMérieux
Roche
BD
Mylab Discovery Solutions
Sysmex Corporation
Siemens Healthineers
Trivitron Healthcare
QIAGEN
Danaher
HiMedia
3B BlackBio Biotech
Abbott
In Chapter 2 and Chapter 15.1, based on types, the Molecular Diagnostics market from 2018 to 2028 is primarily split into:
Instruments
Reagents
Others
In Chapter 3 and Chapter 15.2, based on applications, the Molecular Diagnostics market from 2018 to 2028 covers:
Oncology
Pharmacogenomics
Infectious Diseases
Genetic Testing
Neurological Diseases
others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the Molecular Diagnostics market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028